Top Priority Sector: disaster_preparedness_emergency_response Inovio Pharmaceuticals, Inc. expanded its existing license agreement on Nov. 14 with the University of Pennsylvania (UPenn), adding worldwide rights to technology and intellectual property for novel synthetic vaccines against potential biodefense pathogens, cancer, and infectious diseases. The technologies were developed by UPenn Professor David Weiner…
Chicago CBP lab identifies new illicit synthetic drugs
Mark Rockwell Top Priority Sector: border_security Image Caption: Synthetic amphetamine U.S. customs agents at international mail and courier hub facilities are fighting a rising tide of new designer drugs that mimic marijuana, methamphetamine and other illegal drugs as drug smugglers look for ways to get around U.S. regulations. Homepage position: …
